Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -61.09% | 143.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -61.09% | 143.46% | |||
| Cost of Revenue | -44.09% | 111.70% | |||
| Gross Profit | -70.84% | 166.38% | |||
| SG&A Expenses | -16.40% | -15.11% | |||
| Depreciation & Amortization | -6.25% | 0.00% | |||
| Other Operating Expenses | 215.45% | -222.09% | |||
| Total Operating Expenses | 13.48% | -16.73% | |||
| Operating Income | -157.74% | 262.99% | |||
| Income Before Tax | -156.63% | 266.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -156.63% | 266.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -156.63% | 266.13% | |||
| EBIT | -157.74% | 262.99% | |||
| EBITDA | -157.27% | 264.33% | |||
| EPS Basic | -156.51% | 264.92% | |||
| Normalized Basic EPS | -156.35% | 265.55% | |||
| EPS Diluted | -156.51% | 264.92% | |||
| Normalized Diluted EPS | -156.35% | 265.55% | |||
| Average Basic Shares Outstanding | 0.20% | 0.67% | |||
| Average Diluted Shares Outstanding | 0.20% | 0.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||